Astrazeneca PLC News Headlines

AZN 
$70.91
*  
0.47
0.67%
Get AZN Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading AZN now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Today's Market: Inversions, Tech Deals And Upgrades/Downgrades Moving These Names
10/15/2014 11:32:00 AM - Seeking Alpha


European Stocks Lower on Banking Contractions
10/15/2014 9:50:27 AM - MT Newswires


AbbVie (ABBV) May Not Buy Shire (SHPG), But You Should
10/15/2014 9:07:11 AM - Martin Tillier


AbbVie To Reconsider Shareholder Recommendation On Inversion Deal For Shire
10/14/2014 10:13:00 PM - RTT News


2 Reasons To Invest In Global Dividend-Paying Stocks
10/14/2014 7:40:00 PM - Seeking Alpha


Pfizer's Breast Cancer Candidate Gets Priority Review - Analyst Blog
10/14/2014 5:00:00 PM - Zacks.com


3 Dividend Stocks to Buy If the Market Crashes
10/14/2014 8:14:02 AM - Motley Fool


Targacept's Nine-Year Association with AstraZeneca to End - Analyst Blog
10/13/2014 3:00:00 PM - Zacks.com


Jeffries' rationale for AstraZeneca upgrade relies on less-than-desirable behavior by management
10/13/2014 12:10:00 PM - Seeking Alpha


LONDON MARKETS: U.K. Stocks Take A Breather From Selling; Rio Tinto Gains
10/13/2014 11:58:00 AM - Dow Jones Business News


AstraZeneca's Benralizumab Encourages in Phase II Study - Analyst Blog
10/10/2014 4:52:00 PM - Zacks.com


Illumina Pads Gene Sequencing Lead With Pharma Deals
10/8/2014 3:04:00 PM - Investor's Business Daily


The Most Important Number You Need to Know Before Buying Pfizer Inc. Stock
10/6/2014 9:41:31 AM - Motley Fool


Better Dividend Stock: GlaxoSmithKline PLC or AstraZeneca PLC?
10/4/2014 9:39:02 AM - Motley Fool


Guilty By Association, Theravance Biopharma Is On Sale
10/3/2014 5:00:00 AM - Seeking Alpha


AVEO-Biodesix Reveal Lung Cancer Study Exploratory Data - Analyst Blog
10/2/2014 2:30:00 PM - Zacks.com


ARDX Surges On Study Data, HBIO Opens Wallet, ZGNX On Watch, PTLA Creates Buzz
10/2/2014 3:05:00 AM - RTT News


Bristol-Myers' Opdivo under Review in EU for Lung Cancer - Analyst Blog
10/1/2014 4:00:00 PM - Zacks.com


Ardelyx Phase 2b Trial Of Tenapanor Meets Primary Endpoint
10/1/2014 6:16:00 AM - RTT News


Big News for These 5 Stocks From ESMO
9/30/2014 8:05:02 AM - Motley Fool


Update: AstraZeneca Moves Closer To EU Approval For Moventig
9/30/2014 3:41:00 AM - Seeking Alpha


Nektar/AstraZeneca's Moventig a Step Closer to EU Approval - Analyst Blog
9/29/2014 4:10:00 PM - Zacks.com


Can Pfizer Grow Without A Big Acquisition?
9/29/2014 10:55:00 AM - Seeking Alpha


AstraZeneca Presents New Data From Investigational Cancer Drug Pipeline At ESMO
9/29/2014 2:19:00 AM - RTT News


AMBI Snapped Up, ALIM''s Iluvien Gets FDA Nod, GLYC Faces Glitch In Study
9/29/2014 2:04:00 AM - RTT News